A Rehabilitative Approach in Patients With Parkinson's Disease
Impact of Mézières Rehabilitative Method in Patients With Parkinson's Disease: a Randomized Controlled Trial
1 other identifier
interventional
36
1 country
1
Brief Summary
The purpose of the study is to evaluate the effectiveness of a rehabilitative approach using breathing and relaxation techniques, and specifically the elongation of the latissimus dorsi muscle according to the Mézières Method to improve balance and posture and relief pain in patients with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 31, 2016
CompletedFirst Posted
Study publicly available on registry
September 7, 2016
CompletedJuly 6, 2017
July 1, 2017
2 months
August 31, 2016
July 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Berg Balance Scale (BBS) from baseline to 12 weeks
It is a widely used clinical tests to evaluate static and dynamic balance of a subject. The total score is 56 (\> 45 safe walking without aids/low tendency to fall, \> 35 safe walking with aids). The test lasts 15-20 minutes, and includes 14 simple tasks. The success in achieving each task is evaluated assigned a score from zero (dependent) to four (independent), and the final measure is the sum of all scores. The scale is considered the gold standard for providing useful information on the predictive estimation of the risk of falls.
Baseline, 4 weeks, 12 weeks
Secondary Outcomes (6)
Change of Visual Analogue Scale (VAS) from baseline to 12 weeks
Baseline, 4 weeks, 12 weeks
Change of Unified Parkinson's Disease Rating Scale (UPDRS) from baseline to 12 weeks
Baseline, 4 weeks, 12 weeks
Change of Functional Gait Assessment (FGA) from baseline to 12 weeks
Baseline, 4 weeks, 12 weeks
Change of Clinical Evaluation of Posture from baseline to 12 weeks
Baseline, 4 weeks, 12 weeks
Change of Modified Parkinson Activity Scale (MPAS) from baseline to 12 weeks
Baseline, 4 weeks, 12 weeks
- +1 more secondary outcomes
Study Arms (2)
Mézières Method group
EXPERIMENTALSessions of exercises for the recovery of midline symmetry, diaphragmatic breathing exercises, stretching of the latissimus dorsi respecting the global elongation according to the Mézières Method.
Home based exercise program group
ACTIVE COMPARATORSessions of home based exercises performed by the patients at their domicile after a training session about the exercise program made by a physiotherapy. The exercises aimed at promoting trunk control in static and dynamic position according to the specific guidelines for Parkinson's disease and proprioceptive exercises for the recovery of balance. An illustrated exercises booklet was given to the patient.
Interventions
10 sessions of rehabilitative treatment according to the Mézières Method, 2 sessions per week for 5 weeks, each lasting 1 hour.
1 single training session lasting 1 hour for the explication of the rehabilitation program that the patient has to perform independently at home followed by 2 sessions of home based exercises per week for 5 weeks, each lasting 1 hour.
Eligibility Criteria
You may qualify if:
- Diagnosis od idiopathic Parkinson's disease (according to UK Brain Bank Criteria), Hoehn-Yahr stage ≤3 (determined during "on phase"), Mini Mental State Examination (MMSE) \> or = 27, no rehabilitation treatment carried out within 3 months prior to the study, diagnosis of Parkinson's disease by at least 5 years.
You may not qualify if:
- Dyskinesias
- Severe fluctuations "on-off"
- Modifications of anti-Parkinsonian drug therapy during the three months prior to the start of the study)
- Sensitivity deficit of the trunk or lower extremities (physical examination)
- Vestibular disorders or paroxysmal vertigo
- Previous thoracic or abdominal surgery
- Other neurological or orthopedic conditions involving the trunk or lower extremities (musculoskeletal diseases, severe osteoarthritis, peripheral neuropathy, prosthetic surgery)
- Cardiovascular comorbidities (recent myocardial infarction, heart failure, uncontrolled hypertension, orthostatic hypotension)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Umberto I Hospital
Rome, 00165, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Vincenzo Maria Saraceni
Sapienza University of Rome, Policlinico Umberto I hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director
Study Record Dates
First Submitted
August 31, 2016
First Posted
September 7, 2016
Study Start
July 1, 2015
Primary Completion
September 1, 2015
Study Completion
January 1, 2016
Last Updated
July 6, 2017
Record last verified: 2017-07